DAWN
Price
$6.74
Change
+$0.13 (+1.97%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
670.01M
41 days until earnings call
DNLI
Price
$14.90
Change
+$0.95 (+6.81%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
2.03B
29 days until earnings call
Interact to see
Advertisement

DAWN vs DNLI

Header iconDAWN vs DNLI Comparison
Open Charts DAWN vs DNLIBanner chart's image
Day One Biopharmaceuticals
Price$6.74
Change+$0.13 (+1.97%)
Volume$45.61K
Capitalization670.01M
Denali Therapeutics
Price$14.90
Change+$0.95 (+6.81%)
Volume$28.86K
Capitalization2.03B
DAWN vs DNLI Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. DNLI commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a StrongBuy and DNLI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (DAWN: $6.61 vs. DNLI: $13.95)
Brand notoriety: DAWN and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 100% vs. DNLI: 149%
Market capitalization -- DAWN: $670.01M vs. DNLI: $2.03B
DAWN [@Biotechnology] is valued at $670.01M. DNLI’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 2 bullish TA indicator(s).

  • DAWN’s TA Score: 4 bullish, 4 bearish.
  • DNLI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than DNLI.

Price Growth

DAWN (@Biotechnology) experienced а +2.01% price change this week, while DNLI (@Biotechnology) price change was -3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

DAWN is expected to report earnings on Aug 12, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.03B) has a higher market cap than DAWN($670M). DNLI YTD gains are higher at: -31.551 vs. DAWN (-47.830). DAWN has higher annual earnings (EBITDA): -188.76M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. DAWN (473M). DAWN has less debt than DNLI: DAWN (2.92M) vs DNLI (48.6M). DAWN has higher revenues than DNLI: DAWN (162M) vs DNLI (0).
DAWNDNLIDAWN / DNLI
Capitalization670M2.03B33%
EBITDA-188.76M-505.16M37%
Gain YTD-47.830-31.551152%
P/E RatioN/AN/A-
Revenue162M0-
Total Cash473M818M58%
Total Debt2.92M48.6M6%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNDNLI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRMIX15.580.11
+0.71%
iShares Russell Mid-Cap Index Instl
OGEAX92.97N/A
N/A
JPMorgan Equity Index A
PPQJX3.64N/A
N/A
Principal MidCap Growth III J
UIPMX30.20N/A
N/A
Victory Precious Metals & Minerals Instl
MLMSX22.55N/A
N/A
Morgan Stanley Instl Global Core R6